Join the Ischemic Stroke - Prophylaxis group to help and get support from people like you.
Ischemic Stroke - Prophylaxis News (Page 6)
Related terms: Stroke, ischemic, Prophylaxis
Women With LVO Acute Ischemic Stroke Less Likely to Be Routed to Stroke Centers
WEDNESDAY, July 26, 2023 – Women with large vessel occlusion (LVO) acute ischemic stroke (AIS) are less likely to be routed to comprehensive stroke centers (CSCs) compared with men, despite...
Brilinta Approved in the US to Reduce the Risk of Stroke in Patients with an Acute Ischemic Stroke or High-Risk Transient Ischemic Attack
6 November 2020 – AstraZeneca’s Brilinta (ticagrelor) has been approved in the US to reduce the risk of stroke, a leading cause of disability and death worldwide, in patients with acute ischemic str...
Victoza (liraglutide) is Approved to Reduce the Risk of Three Major Adverse Cardiovascular Events in Type 2 Diabetes Patients
PLAINSBORO, N.J., Aug. 25, 2017 /PRNewswire/ – The U.S. Food and Drug Administration (FDA) has approved a new indication for Victoza (liraglutide) to reduce the risk of major adverse cardiovascular...
FDA Approves Durlaza (aspirin) ER Capsules for Secondary Prevention of Stroke and Acute Cardiac Events
New Haven, CT, September 8th, 2015 – New Haven Pharmaceuticals, Inc. a privately held specialty pharmaceuticals company, today announced that the U.S. Food and Drug Administration (FDA) has approved D...
FDA Approves Zontivity to Reduce the Risk of Heart Attacks and Stroke
May 8, 2014 – The U.S. Food and Drug Administration today approved Zontivity (vorapaxar) tablets to reduce the risk of heart attack, stroke, cardiovascular death, and need for procedures to restore...
Ask a question
To post your own question to this support group, sign in or create an account.
Further information
Related condition support groups
Related drug support groups
aspirin, Plavix, pravastatin, clopidogrel, Brilinta, Arthritis Pain, ticagrelor